HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 116 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $271,000 | -30.0% | 30,584 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $387,000 | -33.2% | 30,584 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $579,000 | -27.4% | 30,584 | +36.8% | 0.00% | -33.3% |
Q4 2021 | $797,000 | -2.7% | 22,361 | 0.0% | 0.00% | -25.0% |
Q3 2021 | $819,000 | +29.0% | 22,361 | +38.2% | 0.00% | +33.3% |
Q2 2021 | $635,000 | +38.9% | 16,179 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $457,000 | -11.8% | 16,179 | 0.0% | 0.00% | -25.0% |
Q4 2020 | $518,000 | +28.9% | 16,179 | +30.1% | 0.00% | 0.0% |
Q3 2020 | $402,000 | -5.9% | 12,434 | -19.7% | 0.00% | -20.0% |
Q2 2020 | $427,000 | +120.1% | 15,480 | +42.4% | 0.01% | +66.7% |
Q1 2020 | $194,000 | -32.6% | 10,867 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $288,000 | +48.5% | 10,867 | 0.0% | 0.00% | +33.3% |
Q3 2019 | $194,000 | +25.2% | 10,867 | +54.4% | 0.00% | 0.0% |
Q2 2019 | $155,000 | -27.9% | 7,038 | 0.0% | 0.00% | -25.0% |
Q1 2019 | $215,000 | +39.6% | 7,038 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $154,000 | – | 7,038 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |